We propose a model of CISD2–ROS–EGR1/GPX3 axis signaling (Fig. 7), in which increased levels of CISD2 contribute to the neutralization of excessive ROS production, which would otherwise increase antitumor activity mediated at least by the tumor suppressors EGR1 and GPX3. The gene discussed is CISD2; the disease is neoplasm.